About ZIEXTENZO

ZIEXTENZO is a medicine that contains the active ingredient PEGFILGRASTIM, which is used to stimulate the production of white blood cells, particularly neutrophils, in the body. This is crucial for patients undergoing chemotherapy, as it helps to reduce the risk of infection. ZIEXTENZO is administered via injection and is designed to support the recovery of the immune system after chemotherapy.

Key Benefits & Uses

Reduces the duration of neutropenia, a condition characterized by low levels of neutrophils in the blood
Decreases the incidence of febrile neutropenia, a potentially life-threatening condition
Supports the recovery of the immune system after chemotherapy, reducing the risk of infection

Active Ingredient & Action

PEGFILGRASTIM works by stimulating the production of granulocytes, a type of white blood cell, in the bone marrow. This leads to an increase in the levels of neutrophils in the blood, which helps to fight off infections. By reducing the duration and incidence of neutropenia, PEGFILGRASTIM helps to minimize the risk of infection and support the overall recovery of patients undergoing chemotherapy.

Important Notes

It is essential to follow the instructions of a healthcare professional when using ZIEXTENZO. Patients should be monitored for any signs of allergic reactions or other adverse effects. Additionally, ZIEXTENZO should only be used under the guidance of a qualified healthcare professional, as it is a prescription-only medicine. Patients should not self-administer ZIEXTENZO or use it for any purpose other than that prescribed by their doctor.